CVALF
Price
$1.53
Change
-$0.07 (-4.38%)
Updated
Sep 26 closing price
Capitalization
42.02M
GNFT
Price
$3.61
Change
+$0.06 (+1.69%)
Updated
Sep 29, 01:23 PM (EDT)
Capitalization
182.52M
52 days until earnings call
Interact to see
Advertisement

CVALF vs GNFT

Header iconCVALF vs GNFT Comparison
Open Charts CVALF vs GNFTBanner chart's image
Covalon Technologies
Price$1.53
Change-$0.07 (-4.38%)
Volume$2.2K
Capitalization42.02M
Genfit SA
Price$3.61
Change+$0.06 (+1.69%)
Volume$500
Capitalization182.52M
CVALF vs GNFT Comparison Chart in %
Loading...
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CVALF vs. GNFT commentary
Sep 29, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CVALF is a Hold and GNFT is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 29, 2025
Stock price -- (CVALF: $1.53 vs. GNFT: $3.55)
Brand notoriety: CVALF and GNFT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CVALF: 31% vs. GNFT: 155%
Market capitalization -- CVALF: $42.02M vs. GNFT: $182.52M
CVALF [@Biotechnology] is valued at $42.02M. GNFT’s [@Biotechnology] market capitalization is $182.52M. The market cap for tickers in the [@Biotechnology] industry ranges from $98.9B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CVALF’s FA Score shows that 0 FA rating(s) are green whileGNFT’s FA Score has 1 green FA rating(s).

  • CVALF’s FA Score: 0 green, 5 red.
  • GNFT’s FA Score: 1 green, 4 red.
According to our system of comparison, GNFT is a better buy in the long-term than CVALF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CVALF’s TA Score shows that 3 TA indicator(s) are bullish while GNFT’s TA Score has 5 bullish TA indicator(s).

  • CVALF’s TA Score: 3 bullish, 6 bearish.
  • GNFT’s TA Score: 5 bullish, 6 bearish.
According to our system of comparison, GNFT is a better buy in the short-term than CVALF.

Price Growth

CVALF (@Biotechnology) experienced а -5.20% price change this week, while GNFT (@Biotechnology) price change was -18.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.00%. For the same industry, the average monthly price growth was +11.11%, and the average quarterly price growth was +59.53%.

Reported Earning Dates

GNFT is expected to report earnings on Nov 20, 2025.

Industries' Descriptions

@Biotechnology (+2.00% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GNFT($183M) has a higher market cap than CVALF($42M). GNFT has higher P/E ratio than CVALF: GNFT (103.10) vs CVALF (23.63). GNFT YTD gains are higher at: -4.441 vs. CVALF (-31.696).
CVALFGNFTCVALF / GNFT
Capitalization42M183M23%
EBITDA3.14MN/A-
Gain YTD-31.696-4.441714%
P/E Ratio23.63103.1023%
Revenue33MN/A-
Total Cash18.1MN/A-
Total Debt1.28MN/A-
FUNDAMENTALS RATINGS
CVALF vs GNFT: Fundamental Ratings
CVALF
GNFT
OUTLOOK RATING
1..100
5052
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
80
Overvalued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
7497
PRICE GROWTH RATING
1..100
8583
P/E GROWTH RATING
1..100
752
SEASONALITY SCORE
1..100
n/a39

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CVALF's Valuation (61) in the null industry is in the same range as GNFT (80) in the Biotechnology industry. This means that CVALF’s stock grew similarly to GNFT’s over the last 12 months.

CVALF's Profit vs Risk Rating (72) in the null industry is in the same range as GNFT (100) in the Biotechnology industry. This means that CVALF’s stock grew similarly to GNFT’s over the last 12 months.

CVALF's SMR Rating (74) in the null industry is in the same range as GNFT (97) in the Biotechnology industry. This means that CVALF’s stock grew similarly to GNFT’s over the last 12 months.

GNFT's Price Growth Rating (83) in the Biotechnology industry is in the same range as CVALF (85) in the null industry. This means that GNFT’s stock grew similarly to CVALF’s over the last 12 months.

GNFT's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for CVALF (75) in the null industry. This means that GNFT’s stock grew significantly faster than CVALF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CVALFGNFT
RSI
ODDS (%)
Bullish Trend 4 days ago
75%
Bullish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
76%
Momentum
ODDS (%)
Bearish Trend 6 days ago
68%
Bearish Trend 4 days ago
85%
MACD
ODDS (%)
Bearish Trend 4 days ago
75%
Bearish Trend 4 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
63%
Bearish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 15 days ago
70%
Declines
ODDS (%)
Bearish Trend 26 days ago
69%
Bearish Trend 7 days ago
84%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bearish Trend 4 days ago
72%
Bearish Trend 4 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
CVALF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GNFT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MUSLF0.040.01
+18.33%
Promino Nutritional Sciences Inc.
ABMRF32.651.53
+4.90%
ABN Amro Group NV
BVSFF1.15N/A
N/A
Bravura Solutions Ltd.
TRBRF0.57N/A
-0.20%
TRUBAR INC.
NISTF21.55-0.95
-4.22%
Nippon Steel Corporation

CVALF and

Correlation & Price change

A.I.dvisor tells us that CVALF and SMMT have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CVALF and SMMT's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CVALF
1D Price
Change %
CVALF100%
-4.38%
SMMT - CVALF
27%
Poorly correlated
+3.41%
GNFT - CVALF
25%
Poorly correlated
+0.45%
AKBLF - CVALF
21%
Poorly correlated
N/A
TARA - CVALF
21%
Poorly correlated
-0.93%
MBIO - CVALF
20%
Poorly correlated
-0.62%
More

GNFT and

Correlation & Price change

A.I.dvisor indicates that over the last year, GNFT has been loosely correlated with SPRB. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if GNFT jumps, then SPRB could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNFT
1D Price
Change %
GNFT100%
+0.45%
SPRB - GNFT
39%
Loosely correlated
N/A
CVALF - GNFT
25%
Poorly correlated
-4.38%
ORMP - GNFT
25%
Poorly correlated
+0.42%
GLTO - GNFT
25%
Poorly correlated
-0.90%
CAPR - GNFT
24%
Poorly correlated
+8.74%
More